Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung

[en] In order to assess if oxytocin- and vasopressin-induced mitogenic effects detected on small-cell lung carcinoma (SCLC) cell lines could be transposed on primary SCLC, the aim of the present work was to identify mediators of these mitogenic actions on primary tumours samples. This was addressed on normal human lung tissue, on SCLC and on non-SCLC (NSCLC). Herein, we observe, in normal human lung, that OTR is colocalized with vascular endothelial cells of the lung and is not expressed by lung cells of epithelial nature. We detected mRNA amplification of V1aR, V2R and of a V2R variant. We observed that 86% of SCLC biopsies analyzed expressed at least the OTR and that 71% expressed the OTR, the V1aR and the V2R altogether. Comparatively, 50% of NSCLC biopsies tested expressed at least the OTR and 32% expressed the OTR, the V1aR and the V2R altogether. The occurrence of the V1bR/V3R is of 28 and 18% for SCLC and NSCLC, respectively. Nevertheless, for the SCLC biopsies analyzed in this study, V1bR/V3R expression correlates, in all cases, with the expression of all the other neurohypophysial peptide receptors. Our results suggest that neurohypophysial peptide antagonists may offer promise as a potential new therapeutic modality for the treatment of lung cancer expressing at least one of the neurhypophysial peptide receptor subtypes. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

Disciplines :

Cardiovascular & respiratory systems
Oncology

Author, co-author :

Pequeux, Christel ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement

Breton, C.

Hagelstein, M. T.

Geenen, Vincent ; Université de Liège - ULiège > Centre d'immunologie

Legros, Jean-Jacques ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques

Language :

English

Title :

Oxytocin receptor pattern of expression in primary lung cancer and in normal human lung

Publication date :

November 2005

Journal title :

Lung Cancer

ISSN :

0169-5002

eISSN :

1872-8332

Publisher :

Elsevier Ireland Ltd, Clare, Ireland

Volume :

Issue :

Pages :

177-188

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 19 October 2009

Statistics

Number of views

133 (1 by ULiège)

Number of downloads

357 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

K.-M. Müller Lung cancer: morphology. S.G. Spiro S.G. Spiro European respiratory monograph, lung cancer 2001 European respiratory Society UK 34 47
G.K. Dy, and A.A. Adjei Novel targets for lung cancer therapy: part I J Clin Oncol 20 2002 2881 2894
D.V. Johnson, and C.D. Blanke Small cell lung cancer: diagnosis, treatment and natural history A.P. Fishman A.P. Fishman Fishman's pulmonary diseases and disorders 1998 McGraw-Hill Health Professions Division NY 1819 1831 [chapter 114]
H. Skuladottir, and J.H. Olsen Epidemiology of lung cancer S.G. Spiro S.G. Spiro European respiratory monograph, lung cancer. 2001 European respiratory Society UK 1 12
A.C. Kraus, I. Ferber, S.O. Bachmann, H. Specht, A. Wimmel, and M.W. Gross In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways Oncogene 21 2002 8683 8695
U. Gatzemeier, and M. Reck New chemotherapeutic agents S.G. Spiro S.G. Spiro European respiratory monograph, lung cancer. 2001 European respiratory Society UK 259 269
A. Spira, and D.S. Ettinger Multidisciplinary management of lung cancer N Engl J Med 350 2004 379 392
W.G. North Gene regulation of vasopressin and vasopressin receptors in cancer [Review] [101 refs] Exp Physiol 85 2000 27S 40S
E. Rozengurt Autocrine loops, signal transduction, and cell cycle abnormalities in the molecular biology of lung cancer Curr Opin Oncol 11 1999 116 122
E. Rozengurt Neuropeptides as growth factors for normal and cancerous cells Trends Endocrinol Metab 13 2002 128 134
L.E. Heasley Autocrine and paracrine signaling through neuropeptide receptors in human cancer Oncogene 20 2001 1563 1569
W.B. Schwartz, W. Bennet, S. Curelop, and F.C. Bartter A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone Am J Med 23 1957 529
T.T. Amatruda, P.J. Mulrow, J.C. Gallagher, and W.H. Sawyer Carcinoma of the lung with inappropriate antidiuresis. Demonstration of an antidiuretic-hormone-like activity in tumor extract N Engl J Med 269 1963 544
B.F. Bower, D.M. Mason, and P.H. Forsham Bronchogenic carcinoma with inappropriate antidiuretic activity in plasma and tumor N Engl J Med 271 1964 934
F.C. Bartter, and W.B. Schwartz The syndrome of inappropriate secretion of antidiuretic hormone [Review] [154 refs] Am J Med 42 1967 790 806
W.G. North, M.J. Fay, K.A. Longo, and J. Du Expression of all known vasopressin receptor subtypes by small cell tumors implies a multifaceted role for this neuropeptide Cancer Res 58 1998 1866 1871
C. Péqueux, C. Breton, J.-C. Hendrick, M-T. Hagelstein, H. Martens, and R. Winkler Oxytocin synthesis and oxytocin receptor expression by cell lines of human small cell carcinoma of the lung stimulate tumor growth through an autocrine/paracrine signaling Cancer Res 62 2002 4623 4629
J.J. Legros, V. Geenen, T. Carvelli, H. Martens, M. Andre, and J.L. Corhay Neurophysins as markers of vasopressin and oxytocin release. A study in carcinoma of the lung Hormone Res 34 1990 151 155
W.G. North, A.S. Friedmann, and X. Yu Tumor biosynthesis of vasopressin and oxytocin [Review] [47 refs] Ann N Y Acad Sci 689 1993 107 121
C. Péqueux, J.-C. Hendrick, M.-T. Hagelstein, V. Geenen, and J.-J. Legros Novel plasma extraction procedure and development of a specific enzyme-immunoassay of oxytocin: application to clinical and biological investigations of small cell carcinoma of the lung Scand J Clin Lab Invest 61 2001 407 416
P. Cassoni, T. Marrocco, S. Deaglio, A. Sapino, and G. Bussolati Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors Ann Oncol 12 2001 S37 S39
G. Bussolati, and P. Cassoni Editorial: the oxytocin/oxytocin receptor system-expect the unexpected Endocrinology 142 2001 1377 1379
C. Péqueux, B.P. Keegan, M.-T. Hagelstein, V. Geenen, J.-J. Legros, and W.G. North Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway Endocr Relat Cancer 11 2004 871 885
A. Hirasawa, K. Hashimoto, and G. Tsujimoto Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats Eur J Pharmacol 267 1994 71 75
A. Tahara, Y. Tomura, K. Wada, T. Kusayama, J. Tsukada, and N. Ishii Characterization of vasopressin receptor in rat lung Neuropeptides 32 1998 281 286
S.J. Lolait, A.M. O'Carroll, L.C. Mahan, C.C. Felder, D.C. Button, and W.S. Young 3rd Extrapituitary expression of the rat V1b vasopressin receptor gene Proc Natl Acad Sci USA 92 1995 6783 6787
M.J. Fay, J. Du, X. Yu, and W.G. North Evidence for expression of vasopressin V2 receptor mRNA in human lung Peptides 17 1996 477 481
J.E. Kaufmann, A. Oksche, C.B. Wollheim, G. Gunther, W. Rosenthal, and U.M. Vischer Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP J Clin Invest 106 2000 107 116
G. Gimpl, and F. Fahrenholz The oxytocin receptor system: structure, function, and regulation Physiol Rev 81 2001 629 683
H.H. Zingg, and S.A. Laporte The oxytocin receptor Trends Endocrinol Metab 14 2003 222 227
G. Bussolati, P. Cassoni, G. Ghisolfi, F. Negro, and A. Sapino Immunolocalization and gene expression of oxytocin receptors in carcinomas and non-neoplastic tissues of the breast Am J Pathol 148 1996 1895 1903
T. Kimura, O. Tanizawa, K. Mori, M.J. Brownstein, and H. Okayama Structure and expression of a human oxytocin receptor [published erratum appears in Nature 1992 May 14;357(6374):176] Nature 356 1992 526 529
M. Thibonnier, C. Auzan, Z. Madhun, P. Wilkins, L. Berti-Mattera, and E. Clauser Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor J Biol Chem 269 1994 3304 3310
T. Sugimoto, M. Saito, S. Mochizuki, Y. Watanabe, S. Hashimoto, and H. Kawashima Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor J Biol Chem 269 1994 27088 27092
M. Birnbaumer, A. Seibold, S. Gilbert, M. Ishido, C. Barberis, and A. Antaramian Molecular cloning of the receptor for human antidiuretic hormone Nature 357 1992 333 335
G.A. Blobel, V.E. Gould, R. Moll, I. Lee, M. Huszar, and B. Geiger Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms Lab Invest 52 1985 39 51
K. Kayser, W. Schmid, W. Ebert, and B. Wiedenmann Expression of neuroendocrine markers (neuronspecific enolase, synaptophysin and bombesin) in carcinoma of the lung Pathol Res Pract 183 1988 412 417
W. Ebert, T. Muley, and P. Drings Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Res 16 1996 2161 2168
T. Muley, W. Ebert, P. Stieber, H. Raith, S. Holdenrieder, and D. Nagel Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay Clin Chem Lab Med 41 2003 95 103
R. Moll, W.W. Franke, D.L. Schiller, B. Geiger, and R. Krepler The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells Cell 31 1982 11 24
M. Thibonnier, D.M. Conarty, J.A. Preston, C.L. Plesnicher, R.A. Dweik, and S.C. Erzurum Human vascular endothelial cells express oxytocin receptors Endocrinology 140 1999 1301 1309
M. Jankowski, D. Wang, F. Hajjar, S. Mukaddam-Daher, S.M. McCann, and J. Gutkowska Oxytocin and its receptors are synthesized in the rat vasculature Proc Natl Acad Sci USA 97 2000 6207 6211
T. Sethi, and E. Rozengurt Multiple neuropeptides stimulate clonal growth of small cell lung cancer: effects of bradykinin, vasopressin, cholecystokinin, galanin, and neurotensin Cancer Res 51 1991 3621 3623
A.P. Meert, B. Martin, J.M. Verdebout, M. Paesmans, T. Berghmans, and V. Ninane Correlation of different markers (p53, EGF-R, c-erbB-2, Ki-67) expression in the diagnostic biopsies and the corresponding resected tumors in non-small cell lung cancer Lung Cancer 44 2004 295 301
W.G. North, M.J. Fay, and J. Du All three vasopressin receptor sub-types are expressed by small-cell carcinoma Adv Exp Med Biol 449 1998 335 338
W.G. North, M.J. Fay, and J. Du MCF-7 breast cancer cells express normal forms of all vasopressin receptors plus an abnormal V2R Peptides 20 1999 837 842
D. Firsov, B. Mandon, A. Morel, J. Merot, S. Le Maout, and A.C. Bellanger Molecular analysis of vasopressin receptors in the rat nephron. Evidence for alternative splicing of the V2 receptor Pflugers Arch 429 1994 79 89